Acasunlimab (GEN1046), a bispecific antibody (bsAb) designed to target PD-L1 and 4-1BB, functions by enhancing both T-cell and NK-cell response via conditional 4-1BB stimulation and continuously inhibiting the PD-1/PD-L1 axis. This compound is applicable in cancer research [1] [2].
CAS Number:
[2253937-12-9]
Target:
PD-1/PD-L1
* VAT and and shipping costs not included. Errors and price changes excepted
